*ST Jiyou plans 1.01 billion yuan pharmaceutical acquisition amid delisting risk

The packaging and printing company aims to buy 50.76% of Wisdom Pharmaceutical at a 126.63% premium, while its controlling shareholder arranges a parallel share transfer.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.